Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-19,178
Closed -$1.56M 1965
2024
Q3
$1.56M Sell
19,178
-770
-4% -$61.6K 0.01% 938
2024
Q2
$1.48M Buy
19,948
+3,753
+23% +$281K 0.01% 871
2024
Q1
$1.26M Sell
16,195
-1,597
-9% -$119K 0.01% 878
2023
Q4
$1.27M Sell
17,792
-4,910
-22% -$342K 0.01% 792
2023
Q3
$1.58M Buy
22,702
+5,081
+29% +$384K 0.01% 652
2023
Q2
$1.43M Buy
+17,621
New +$1.44M ﹤0.01% 775
2019
Q2
Sell
-282
Closed -$14K 990
2019
Q1
$14K Buy
282
+89
+46% +$4.01K ﹤0.01% 1108
2018
Q4
$8K Buy
+193
New +$7.92K ﹤0.01% 907

Other funds holding HOLX

Cresset Asset Management's HOLX Position: Q4 2024 in Review

Cresset Asset Management sold out of Hologic (HOLX) in Q4 2024, closing a stake of 19,178 shares — an estimated $1.56M sold.

Cresset Asset Management first reported a position in HOLX in Q4 2018 and held it in 8 quarters. The position peaked at $1.58M in Q3 2023. 719 funds tracked by Wall St. Rank hold HOLX as of Q4 2024.

  • Cresset Asset Management reported no remaining Hologic position as of Q4 2024 after selling out during the quarter.
  • Cresset Asset Management sold 19,178 Hologic shares in Q4 2024, an estimated $1.56M.
  • Cresset Asset Management first reported a position in Hologic in Q4 2018 and held it in 8 quarters.
  • Cresset Asset Management's Hologic position peaked at $1.58M in Q3 2023.
  • 719 funds tracked by Wall St. Rank held Hologic as of Q4 2024.

Based on Cresset Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.